Genomic insights into the genetic diversity, resistance determinants, and plasmid content of carbapenem-resistant Acinetobacter baumannii clinical isolates

Key Points

• Carbapenem-resistant Acinetobacter baumannii isolates show significant genetic diversity, emphasizing the need for surveillance.
• Key resistance determinants and plasmid content analysis highlights mechanisms driving antibiotic resistance.
• Assessment involves genomic sequencing to understand the genetic basis of resistance in clinical isolates.
• These insights may inform treatment strategies, but underscore the urgent need for new therapeutic options.